M&A / Deals Sun sets out $11.75bn takeover play for Organon PharmaphorumAfter downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for Organon.Read full story pharminent April 27, 2026 (Last updated: April 27, 2026) Pharmaphorum After downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for Organon. Read full story Post navigation Previous: Gene therapy leaders aim to help more Baby KJs with novel regulatory modelsNext: Sun Pharma to acquire Organon for $11.75bn Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026